On-Demand Webcast

Share

Program Content

Activities

  • HR Positive HER2 Negative Breast Cancer at ASCO 2024
    Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 17, 2024

    Expires: June 16, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation